OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
October 31, 2019
Healthy companies with coherent integration strategies will benefit from applying six lessons to ensure successful integration, writes Mark Bouch.
August 23, 2019
A key question for an organization post-M&A is: “What organizational capabilities support global guidance and leadership, and which of them require these at the 'local' level?” Scott Hull discusses potential solutions.
February 06, 2019
What the new rules mean for Chinese-related investments and acquisitions in the US.
November 14, 2018
The increase in new drug approvals and candidates in development are good signs for pharma and biotech, but both sectors face continued pricing, cost, and healthcare policy-related challenges ahead.
August 08, 2018
New trends report spotlights the promise and cautions for prospective life sciences dealmakers.
August 02, 2018
A list of four ways the pharma industry can save money on travel-related employee expenses regarding VAT on clinical trials, clinical trial supplies, sourcing, and more.
July 18, 2018
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi.
April 10, 2018
Jo Pisani and Cynthia Chan outline the key legal considerations for post-deal integration.
February 02, 2018
2017 was a year of swings and momentum for the pharma and biotech markets. Is more stable footing ahead?
January 03, 2018